Type III interferon signaling restricts enterovirus 71 infection of goblet cells

Science Advances

Volumn 5, Issue 3, 2019, Pages

  Good, Charles ^a   Wells, Alexandra I ^a   Coyne, Carolyn B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CELLS; CYTOLOGY; GLYCOPROTEINS;

APICAL SURFACES; CELL FUNCTIONS; ENTEROVIRUS 71; EPITHELIAL BARRIER; EPITHELIAL MONOLAYERS; GASTROINTESTINAL TRACT; INTESTINAL EPITHELIUM; SELECTIVE INDUCTION;

CELL SIGNALING;

INTERFERON; INTERFERON TYPE III;

CELL CULTURE; CELL MEMBRANE PERMEABILITY; ENTEROVIRUS A; ENTEROVIRUS INFECTION; FLUORESCENT ANTIBODY TECHNIQUE; GOBLET CELL; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; GOBLET CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERONS; INTESTINAL MUCOSA; SIGNAL TRANSDUCTION;

EID: 85062029394     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.aau4255     Document Type: Article

References (40)

1. C. C. Y. Yip, S. K. P. Lau, P. C. Y. Woo, K.-Y. Yuen, Human enterovirus 71 epidemics: What's next? Emerg. Health Threats J. 6, 19780 (2013).
2. N. J. Schmidt, E. H. Lennette, H. H. Ho, An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129, 304–309 (1974).
3. W. Xing, Q. Liao, C. Viboud, J. Zhang, J. Sun, J. T. Wu, Z. Chang, F. Liu, V. J. Fang, Y. Zheng, B. J. Cowling, J. K. Varma, J. J. Farrar, G. M. Leung, H. Yu, Hand, foot, and mouth disease in China, 2008-12: An epidemiological study. Lancet Infect. Dis. 14, 308–318 (2014).
4. S.-M. Wang, C.-C. Liu, H.-W. Tseng, J.-R. Wang, C.-C. Huang, Y.-J. Chen, Y.-J. Yang, S.-J. Lin, T.-F. Yeh, Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29, 184–190 (1999).
5. L.-Y. Chang, T.-Y. Lin, K.-H. Hsu, Y.-C. Huang, K.-L. Lin, C. Hsueh, S.-R. Shih, H.-C. Ning, M.-S. Hwang, H.-S. Wang, C.-Y. Lee, Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354, 1682–1686 (1999).
6. C.-C. Liu, H.-W. Tseng, S.-M. Wang, J.-R. Wang, I.-J. Su, An outbreak of enterovirus 71 infection in Taiwan, 1998: Epidemiologic and clinical manifestations. J. Clin. Virol. 17, 23–30 (2000).
7. Y.-F. Wang, C.-T. Chou, H.-Y. Lei, C.-C. Liu, S.-M. Wang, J.-J. Yan, I.-J. Su, J.-R. Wang, T.-M. Yeh, S.-H. Chen, C.-K. Yu, A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78, 7916–7924 (2004).
8. Y. Zhang, W. Cui, L. Liu, J. Wang, H. Zhao, Y. Liao, R. Na, C. Dong, L. Wang, Z. Xie, J. Gao, P. Cui, X. Zhang, Q. Li, Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 91, 1337–1350 (2011).
9. W. X. Khong, B. Yan, H. Yeo, E. L. Tan, J. J. Lee, J. K. W. Ng, V. T. Chow, S. Alonso, A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 86, 2121–2131 (2012).
10. K. Fujii, N. Nagata, Y. Sato, K. C. Ong, K. T. Wong, S. Yamayoshi, M. Shimanuki, H. Shitara, C. Taya, S. Koike, Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. U.S.A. 110, 14753–14758 (2013).
11. S. Yamayoshi, Y. Yamashita, J. Li, N. Hanagata, T. Minowa, T. Takemura, S. Koike, Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15, 798–801 (2009).
12. N. Nagata, H. Shimizu, Y. Ami, Y. Tano, A. Harashima, Y. Suzaki, Y. Sato, T. Miyamura, T. Sata, T. Iwasaki, Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J. Med. Virol. 67, 207–216 (2002).
13. N. Nagata, T. Iwasaki, Y. Ami, Y. Tano, A. Harashima, Y. Suzaki, Y. Sato, H. Hasegawa, T. Sata, T. Miyamura, H. Shimizu, Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 85, 2981–2989 (2004).
14. T. Sato, J. H. van Es, H. J. Snippert, D. E. Stange, R. G. Vries, M. van den Born, N. Barker, N. F. Shroyer, M. van de Wetering, H. Clevers, Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011).
15. W. E. Lanik, M. A. Mara, B. Mihi, C. B. Coyne, M. Good, Stem cell-derived models of viral infections in the gastrointestinal tract. Viruses 10, 124 (2018).
16. C. G. Drummond, A. M. Bolock, C. Ma, C. J. Luke, M. Good, C. B. Coyne, Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner. Proc. Natl. Acad. Sci. U.S.A. 114, 1672–1677 (2017).
17. J. G. In, J. Foulke-Abel, M. K. Estes, N. C. Zachos, O. Kovbasnjuk, M. Donowitz, Human mini-guts: New insights into intestinal physiology and host–pathogen interactions. Nat. Rev. Gastroenterol. Hepatol. 13, 633–642 (2016).
18. M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
19. D. Crowther, J. L. Melnick, The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive. Virology 14, 11–21 (1961).
20. B. Brandenburg, L. Y. Lee, M. Lakadamyali, M. J. Rust, X. Zhuang, J. M. Hogle, Imaging poliovirus entry in live cells. PLOS Biol. 5, e183 (2007).
21. E. Delorme-Axford, Y. Sadovsky, C. B. Coyne, Lipid raft- and SRC family kinase-dependent entry of coxsackievirus B into human placental trophoblasts. J. Virol. 87, 8569–8581 (2013).
22. Y.-W. Lin, H.-Y. Lin, Y.-L. Tsou, E. Chitra, K.-N. Hsiao, H.-Y. Shao, C.-C. Liu, C. Sia, P. Chong, Y.-H. Chow, Human SCARB2-mediated entry and endocytosis of EV71. PLOS ONE 7, e30507 (2012).
23. K. Pervolaraki, M. L. Stanifer, S. Münchau, L. A. Renn, D. Albrecht, S. Kurzhals, E. Senís, D. Grimm, J. Schröder-Braunstein, R. L. Rabin, S. Boulant, Type I and type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut. Front. Immunol. 8, 459 (2017).
24. S. Yamayoshi, S. Iizuka, T. Yamashita, H. Minagawa, K. Mizuta, M. Okamoto, H. Nishimura, K. Sanjoh, N. Katsushima, T. Itagaki, Y. Nagai, K. Fujii, S. Koike, Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J. Virol. 86, 5686–5696 (2012).
25. M. A. Vega, B. Seguí-Real, J. A. García, C. Calés, F. Rodríguez, J. Vanderkerckhove, I. V. Sandoval, Cloning, sequencing, and expression of a cDNA encoding rat LIMP II, a novel 74-kDa lysosomal membrane protein related to the surface adhesion protein CD36. J. Biol. Chem. 266, 16818–16824 (1991).
26. J. T. C. Shieh, J. M. Bergelson, Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J. Virol. 76, 9474–9480 (2002).
27. B. Yang, H. Chuang, K. D. Yang, Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 6, 141 (2009).
28. K. Saxena, L. M. Simon, X.-L. Zeng, S. E. Blutt, S. E. Crawford, N. P. Sastri, U. C. Karandikar, N. J. Ajami, N. C. Zachos, O. Kovbasnjuk, M. Donowitz, M. E. Conner, C. A. Shaw, M. K. Estes, A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc. Natl. Acad. Sci. U.S.A. 114, E570–E579 (2017).
29. P. P. Hernandez, T. Mahlakõiv, I. Yang, V. Schwierzeck, N. Nguyen, F. Guendel, K. Gronke, B. Ryffel, C. Hölscher, L. Dumoutier, J.-C. Renauld, S. Suerbaum, P. Staeheli, A. Diefenbach, Interferon- and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat. Immunol. 16, 698–707 (2015).
30. J. Pott, T. Mahlakoiv, M. Mordstein, C. U. Duerr, T. Michiels, S. Stockinger, P. Staeheli, M. W. Hornef, IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U.S.A. 108, 7944–7949 (2011).
31. J. D. Lin, N. Feng, A. Sen, M. Balan, H. C. Tseng, C. McElrath, S. V. Smirnov, J. Peng, L. L. Yasukawa, R. K. Durbin, J. E. Durbin, H. B. Greenberg, S. V. Kotenko, Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections. PLOS Pathog. 12, e1005600 (2016).
32. M. T. Baldridge, S. Lee, J. J. Brown, N. McAllister, K. Urbanek, T. S. Dermody, T. J. Nice, H. W. Virgin, Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against norovirus and reovirus. J. Virol. 91, e02079-16 (2017).
33. T. J. Nice, M. T. Baldridge, B. T. McCune, J. M. Norman, H. M. Lazear, M. Artyomov, M. S. Diamond, H. W. Virgin, Interferon- cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347, 269–273 (2015).
34. M. T. Baldridge, T. J. Nice, B. T. McCune, C. C. Yokoyama, A. Kambal, M. Wheadon, M. S. Diamond, Y. Ivanova, M. Artyomov, H. W. Virgin, Commensal microbes and interferon- determine persistence of enteric murine norovirus infection. Science 347, 266–269 (2015).
35. K. G. Harris, C. B. Coyne, Enter at your own risk: How enteroviruses navigate the dangerous world of pattern recognition receptor signaling. Cytokine 63, 230–236 (2013).
36. K. Saxena, S. E. Blutt, K. Ettayebi, X.-L. Zeng, J. R. Broughman, S. E. Crawford, U. C. Karandikar, N. P. Sastri, M. E. Conner, A. R. Opekun, D. Y. Graham, W. Qureshi, V. Sherman, J. Foulke-Abel, J. In, O. Kovbasnjuk, N. C. Zachos, M. Donowitz, M. K. Estes, Human intestinal enteroids: A new model to study human rotavirus infection, host restriction, and pathophysiology. J. Virol. 90, 43–56 (2015).
37. S. A. Shaffiey, H. Jia, T. Keane, C. Costello, D. Wasserman, M. Quidgley, J. Dziki, S. Badylak, C. P. Sodhi, J. C. March, D. J. Hackam, Intestinal stem cell growth and differentiation on a tubular scaffold with evaluation in small and large animals. Regen. Med. 11, 45–61 (2016).
38. C. E. Egan, C. P. Sodhi, M. Good, J. Lin, H. Jia, Y. Yamaguchi, P. Lu, C. Ma, M. F. Branca, S. Weyandt, W. B. Fulton, D. F. Niño, T. Prindle Jr., J. A. Ozolek, D. J. Hackam, Toll-like receptor 4–mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J. Clin. Invest. 126, 495–508 (2016).
39. S. Morosky, N. J. Lennemann, C. B. Coyne, BPIFB6 regulates secretory pathway trafficking and enterovirus replication. J. Virol. 90, 5098–5107 (2016).
40. G. Savidis, J. M. Perreira, J. M. Portmann, P. Meraner, Z. Guo, S. Green, A. L. Brass, The IFITMs inhibit Zika virus replication. Cell Rep. 15, 2323–2330 (2016).